More importantly, PD-1+ NK cells were less potent in secreting IFN-γ and had lower antitumor effects than PD-1- NK cells, suggesting that the accumulation of PD-1+ NK cells in lung cancer may be responsible for the dysfunction of NK cells. The gene discussed is PDCD1; the disease is lung carcinoma.